RIV Capital (XCNQ:RIV) FCF Margin % : -294.95% (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RIV Capital FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RIV Capital's Free Cash Flow for the three months ended in Sep. 2023 was C$-6.77 Mil. RIV Capital's Revenue for the three months ended in Sep. 2023 was C$2.30 Mil. Therefore, RIV Capital's FCF Margin % for the quarter that ended in Sep. 2023 was -294.95%.

As of today, RIV Capital's current FCF Yield % is -335.14%.

The historical rank and industry rank for RIV Capital's FCF Margin % or its related term are showing as below:

XCNQ:RIV' s FCF Margin % Range Over the Past 10 Years
Min: -450.69 Med: -64.96 Max: -62.31
Current: -450.69

During the past 6 years, the highest FCF Margin % of RIV Capital was -62.31%. The lowest was -450.69%. And the median was -64.96%.

XCNQ:RIV's FCF Margin % is ranked worse than
94.05% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs XCNQ:RIV: -450.69

RIV Capital FCF Margin % Historical Data

The historical data trend for RIV Capital's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital FCF Margin % Chart

RIV Capital Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-62.31

-66.45

-63.46

-410.03

RIV Capital Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															-180.83	157.36	-1,317.39	-394.18	-294.95

Competitive Comparison of RIV Capital's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RIV Capital's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's FCF Margin % distribution charts can be found below:

* The bar in red indicates where RIV Capital's FCF Margin % falls into.

RIV Capital FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

RIV Capital's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-38.19	/	9.314
	=	-410.03 %

RIV Capital's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-6.772	/	2.296
	=	-294.95 %

RIV Capital FCF Margin % Related Terms

Thank you for viewing the detailed overview of RIV Capital's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

RIV Capital (XCNQ:RIV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CNPOF:USA

Address

40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2

Website

https://www.rivcapital.com

RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.